Adaptive therapy for ovarian cancer: An integrated approach to PARP inhibitor scheduling
M. Strobl, A. Martin, J. West, J. Gallaher, M. Robertson-Tessi, R. Gatenby, R. Wenham, P. Maini, M. Damaghi, A. R. A. Anderson
This study develops an adaptive therapy protocol for PARP inhibitors by combining mathematical modeling and experiments to optimize treatment scheduling and mitigate resistance.
bioRxiv · Mar 22, 2023 · PreprintCancer Biology